Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications.
Yang S, Hwang D, Zhang J, Park J, Yun JP, Lee JM, Nam CW, Shin ES, Doh JH, Chen SL, Kakuta T, Toth GG, Piroth Z, Johnson NP, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Neleman T, van Mieghem NM, Diletti R, Daemen J, Collison D, Collet C, De Bruyne B, Koo BK. Yang S, et al. Among authors: de bruyne b. J Am Heart Assoc. 2023 Sep 5;12(17):e030572. doi: 10.1161/JAHA.123.030572. Epub 2023 Aug 29. J Am Heart Assoc. 2023. PMID: 37642032 Free PMC article.
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
Serruys PW, Daemen J, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins KD, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll HP. Serruys PW, et al. Among authors: de bruyne b. EuroIntervention. 2008 Jan;3(4):450-9. doi: 10.4244/eijv3i4a81. EuroIntervention. 2008. PMID: 19736087
Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.
Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer M, Pijls NH. Tonino PA, et al. Among authors: de bruyne b. J Am Coll Cardiol. 2010 Jun 22;55(25):2816-21. doi: 10.1016/j.jacc.2009.11.096. J Am Coll Cardiol. 2010. PMID: 20579537 Free article. Clinical Trial.
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.
Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, Barbato E, Hamilos M, Mangiacapra F, Heyndrickx GR, Wijns W, Pijls NH, De Bruyne B. Ntalianis A, et al. Among authors: de bruyne b. JACC Cardiovasc Interv. 2010 Dec;3(12):1274-81. doi: 10.1016/j.jcin.2010.08.025. JACC Cardiovasc Interv. 2010. PMID: 21232721 Free article.
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
Brugaletta S, Garcia-Garcia HM, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin ES, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: de bruyne b. EuroIntervention. 2011 Apr;6(9):1110-6. doi: 10.4244/EIJV6I9A193. EuroIntervention. 2011. PMID: 21518685 Clinical Trial.
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
Brugaletta S, Gomez-Lara J, Diletti R, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Garcia-Garcia HM, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: de bruyne b. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):219-28. doi: 10.1002/ccd.22996. Epub 2011 May 11. Catheter Cardiovasc Interv. 2012. PMID: 21563288 Clinical Trial.
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.
Diletti R, Onuma Y, Farooq V, Gomez-Lara J, Brugaletta S, van Geuns RJ, Regar E, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Smits P, Koolen J, Meredith I, Li D, Veldhof S, Rapoza R, Garcia-Garcia HM, Ormiston JA, Serruys PW. Diletti R, et al. Among authors: de bruyne b. J Am Coll Cardiol. 2011 Jul 12;58(3):258-64. doi: 10.1016/j.jacc.2011.02.052. J Am Coll Cardiol. 2011. PMID: 21737016 Free article.
Functional SYNTAX score for risk assessment in multivessel coronary artery disease.
Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, De Bruyne B, Pijls NH, Fearon WF; FAME Study Investigators. Nam CW, et al. Among authors: de bruyne b. J Am Coll Cardiol. 2011 Sep 13;58(12):1211-8. doi: 10.1016/j.jacc.2011.06.020. J Am Coll Cardiol. 2011. PMID: 21903052 Free article. Clinical Trial.
FFR in bifurcation stenting: what have we learned?
Koo BK, De Bruyne B. Koo BK, et al. Among authors: de bruyne b. EuroIntervention. 2010 Dec;6 Suppl J:J94-8. doi: 10.4244/EIJV6SUPJA15. EuroIntervention. 2010. PMID: 21930499 Review.
578 results